Literature DB >> 6451181

Suppression by superoxide dismutase of immune-complex--induced pulmonary alveolitis and dermal inflammation.

J R McCormick, M M Harkin, K J Johnson, P A Ward.   

Abstract

The possible role of oxygen metabolic products in immune-complex--induced injury of rat lung and of dermal blood vessels has been probed with the use of two inhibitors, superoxide dismutase (SOD) and catalase. With the use of the reversed passive Arthus reaction in the skin, local administration of SOD, but not of catalase, blocked the early phase of the tissue injury, as quantitated by the leakage of homologous albumin. The early phases of immune-complex--induced injury of the lung were completely blocked by the parenteral (intraperitoneal) administration of SOD. Except at very high doses, SOD did not interfere with chemotactic-factor--induced release of lysosomal enzymes from rat neutrophils. These data suggest that oxygen metabolic products such as O(2-) may play an important role in the early phases of damage produced in rat alveolar walls and dermal vasculature by the deposition of immune complexes.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6451181      PMCID: PMC1903445     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  19 in total

1.  Acute inflammatory pulmonary reactions induced by chemotactic factors.

Authors:  U Desai; D L Kreutzer; H Showell; C V Arroyave; P A Ward
Journal:  Am J Pathol       Date:  1979-07       Impact factor: 4.307

2.  Biologic role of complement products. Complement-derived leukotactic activity extractable from lesions of immunologic vasculitis.

Authors:  P A Ward; J H Hill
Journal:  J Immunol       Date:  1972-05       Impact factor: 5.422

3.  Free radicals and inflammation: superoxide-dependent activation of a neutrophil chemotactic factor in plasma.

Authors:  W F Petrone; D K English; K Wong; J M McCord
Journal:  Proc Natl Acad Sci U S A       Date:  1980-02       Impact factor: 11.205

4.  Biochemical quantitation of the chemotactic factor inactivator activity in human serum.

Authors:  J Fantone; R M Senior; D L Kreutzer; M Jones; P A Ward
Journal:  J Lab Clin Med       Date:  1979-01

5.  Immune complexes and humoral response to Pseudomonas aeruginosa in cystic fibrosis.

Authors:  R B Moss; N J Lewiston
Journal:  Am Rev Respir Dis       Date:  1980-01

6.  Free radicals and inflammation: protection of synovial fluid by superoxide dismutase.

Authors:  J M McCord
Journal:  Science       Date:  1974-08-09       Impact factor: 47.728

7.  Circulating immune complexes in pulmonary eosinophilic granuloma.

Authors:  T E King; M I Schwarz; R E Dreisin; D S Pratt; A N Theofilopoulos
Journal:  Ann Intern Med       Date:  1979-09       Impact factor: 25.391

8.  Changes in membrane potential of human granulocytes antecede the metabolic responses to surface stimulation.

Authors:  H M Korchak; G Weissmann
Journal:  Proc Natl Acad Sci U S A       Date:  1978-08       Impact factor: 11.205

9.  Acute immunologic pulmonary alveolitis.

Authors:  K J Johnson; P A Ward
Journal:  J Clin Invest       Date:  1974-08       Impact factor: 14.808

10.  BOUND COMPLEMENT AND IMMUNOLOGIC INJURY OF BLOOD VESSELS.

Authors:  P A WARD; C G COCHRANE
Journal:  J Exp Med       Date:  1965-02-01       Impact factor: 14.307

View more
  30 in total

1.  Interaction of polymorphonuclear leucocytes with patellar cartilage of immobilised arthritic joints: a scanning electron microscopic study.

Authors:  P L van Lent; F H Wilms; W B van den Berg
Journal:  Ann Rheum Dis       Date:  1989-10       Impact factor: 19.103

2.  Human vascular smooth muscle cells and endothelial cells lack catalase activity and are susceptible to hydrogen peroxide.

Authors:  M Shingu; K Yoshioka; M Nobunaga; K Yoshida
Journal:  Inflammation       Date:  1985-09       Impact factor: 4.092

3.  Protein degradation following treatment with hydrogen peroxide.

Authors:  S E Fligiel; E C Lee; J P McCoy; K J Johnson; J Varani
Journal:  Am J Pathol       Date:  1984-06       Impact factor: 4.307

4.  Role of endotoxin-like contaminants in the apparent anti-inflammatory activity of bovine superoxide dismutase.

Authors:  M Iida; K Saito
Journal:  Inflamm Res       Date:  1996-06       Impact factor: 4.575

5.  Cationization of catalase, peroxidase, and superoxide dismutase. Effect of improved intraarticular retention on experimental arthritis in mice.

Authors:  J Schalkwijk; W B van den Berg; L B van de Putte; L A Joosten; L van den Bersselaar
Journal:  J Clin Invest       Date:  1985-07       Impact factor: 14.808

6.  Monocyte superoxide anion production in rheumatoid arthritis: preliminary evidence for enhanced rates of superoxide anion production by monocytes from patients receiving penicillamine, sodium aurothiomalate and corticosteroids.

Authors:  N P Hurst; B Bessac; G Nuki
Journal:  Ann Rheum Dis       Date:  1984-02       Impact factor: 19.103

7.  Acute and progressive lung injury after contact with phorbol myristate acetate.

Authors:  K J Johnson; P A Ward
Journal:  Am J Pathol       Date:  1982-04       Impact factor: 4.307

8.  Enhanced superoxide anion release from phagocytes by muramyl dipeptide or lipopolysaccharide.

Authors:  M Kaku; K Yagawa; S Nagao; A Tanaka
Journal:  Infect Immun       Date:  1983-02       Impact factor: 3.441

9.  Acute lung inflammation induced in the rabbit by local instillation of 1-0-octadecyl-2-acetyl-sn-glyceryl-3-phosphorylcholine or of native platelet-activating factor.

Authors:  G Camussi; I Pawlowski; C Tetta; C Roffinello; M Alberton; J Brentjens; G Andres
Journal:  Am J Pathol       Date:  1983-07       Impact factor: 4.307

10.  In vitro and in vivo stimulation of rat neutrophils and alveolar macrophages by immune complexes. Production of O-2 and H2O2.

Authors:  P A Ward; R E Duque; M C Sulavik; K J Johnson
Journal:  Am J Pathol       Date:  1983-03       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.